Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-23-054997

President and CEO acquired 198,407 shares (option exercise)

  • President and CEO gave 85,307 shares (gift)
  • President and CEO gave 85,307 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Mack David Henry · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-18 Exercise or conversion : show line 1 in the form +198,407 $0.53 $105,156 363,877 D
2023-11-10 Gift : show line 2 in the form −85,307 278,570 D
2023-11-10 Gift : show line 3 in the form +85,307 165,307 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-07 Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) −198,407 109,459 D
Loading xslF345X05/doc4.xml…